03:55 PM EDT, 06/26/2025 (MT Newswires) -- Health care stocks edged up late Thursday afternoon, with the NYSE Health Care Index rising 0.2% and the Health Care Select Sector SPDR Fund (XLV) fractionally higher.

The iShares Biotechnology ETF (IBB) added 0.1%.

In corporate news, Vor Biopharma ( VOR ) shares surged 80%, a day after the company signed a license deal with RemeGen for global rights, excluding Greater China, to develop and commercialize telitacicept for autoimmune diseases.

3D Systems ( DDD ) shares popped 7% after the firm said collaboration with Tissium has resulted in US Food and Drug Administration approval for 3D-printed polymeric solution for repair of peripheral nerve damage.

Walgreens Boots Alliance ( WBA ) reported fiscal Q3 results above market estimates, even though the drugstore chain was weighed down by weakness in US retail sales. The shares rose 0.5%.

Novo Nordisk ( NVO ) entered into a collaboration with WeightWatchers to expand patient access to its weight-loss drug Wegovy. Novo shares added 0.5%.

ReShape Lifesciences ( RSLS ) shares fell 3%. The firm plans to cut jobs to save $750,000, or 23% of annual payroll expenses.